BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 26966035)

  • 1. [Misleading diagnosis of hyperprolactinemia in women].
    Paepegaey AC; Veron L; Wimmer MC; Christin-Maitre S
    Gynecol Obstet Fertil; 2016 Mar; 44(3):181-6. PubMed ID: 26966035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of macroprolactinemia in hyperprolactinemia.
    Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
    Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
    Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macroprolactinemia in childhood and adolescence: a cause of hyperprolactinemia.
    Tütüncüler F; Darendeliler F; Aygün M; Hekim N
    Turk J Pediatr; 2006; 48(2):143-7. PubMed ID: 16848115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etiological diagnosis of hyperprolactinemia.
    Cortet-Rudelli C; Sapin R; Bonneville JF; Brue T
    Ann Endocrinol (Paris); 2007 Jun; 68(2-3):98-105. PubMed ID: 17524347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory and clinical significance of macroprolactinemia in women with hyperprolactinemia.
    Kasum M; Orešković S; Čehić E; Šunj M; Lila A; Ejubović E
    Taiwan J Obstet Gynecol; 2017 Dec; 56(6):719-724. PubMed ID: 29241908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macroprolactinemia revisited: a study on 106 patients.
    Vallette-Kasic S; Morange-Ramos I; Selim A; Gunz G; Morange S; Enjalbert A; Martin PM; Jaquet P; Brue T
    J Clin Endocrinol Metab; 2002 Feb; 87(2):581-8. PubMed ID: 11836289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pitfalls in the Diagnostic Evaluation of Hyperprolactinemia.
    Vilar L; Vilar CF; Lyra R; Freitas MDC
    Neuroendocrinology; 2019; 109(1):7-19. PubMed ID: 30889571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic evaluation of hyperprolactinemia.
    Biller BM
    J Reprod Med; 1999 Dec; 44(12 Suppl):1095-9. PubMed ID: 10649817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonfunctioning pituitary macroadenoma presenting with mild hyperprolactinemia and amenorrhea.
    Hansen KA; Tho SP; Gomez F; McDonough PG
    Fertil Steril; 1999 Oct; 72(4):663-5. PubMed ID: 10521106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macroprolactinemia in women with hyperprolactinemia: a 10-year follow-up.
    Radavelli-Bagatini S; Lhullier FL; Mallmann ES; Spritzer PM
    Neuro Endocrinol Lett; 2013; 34(3):207-11. PubMed ID: 23685418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
    Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
    Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heterogeneity of immunoreactive prolactin in hyperprolactinemia of various origin].
    Bulatov AA; Makarovskaia EE; Dzeranova LK; Smirnova NB; Chernogolov VA; Marova EI; Mel'nichenko GA; Dedov II
    Probl Endokrinol (Mosk); 1992; 38(6):13-6. PubMed ID: 1302839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of Macroprolactin in Hyperprolactinemia.
    Sherazi NA; Baig MZ; Khan AH
    J Coll Physicians Surg Pak; 2018 Feb; 28(2):93-97. PubMed ID: 29394965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumoral versus non-tumoral hyperprolactinemia in children and adolescents: possible usefulness of the domperidone test.
    Fideleff HL; Azaretzky M; Boquete HR; Pujol AB; Honfi M; Suárez MG; Fideleff G; Giaccio AV
    J Pediatr Endocrinol Metab; 2003 Feb; 16(2):163-7. PubMed ID: 12713252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin Level in Polycystic Ovary Syndrome (PCOS): An approach to the diagnosis and management.
    Davoudi Z; Araghi F; Vahedi M; Mokhtari N; Gheisari M
    Acta Biomed; 2021 Nov; 92(5):e2021291. PubMed ID: 34738596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients.
    Lu CC; Hsieh CJ
    Kaohsiung J Med Sci; 2012 Feb; 28(2):94-9. PubMed ID: 22313536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperprolactinemia: a 12-year retrospective study at gynecologic endocrinology unit, Siriraj Hospital.
    Saejong R; Dangrat C; Techatrisak K; Angsuwatthana S; Rattanachaiyanont M; Tanmahasamut P
    J Med Assoc Thai; 2013 Oct; 96(10):1247-56. PubMed ID: 24350404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the optimal prolactin cutoff for predicting the presence of a pituitary adenoma in patients with polycystic ovary syndrome?
    Kim SI; Yoon JH; Park DC; Yang SH; Kim YI
    Int J Med Sci; 2023; 20(4):463-467. PubMed ID: 37057215
    [No Abstract]   [Full Text] [Related]  

  • 20. Macroprolactinemia: a new cause of hyperprolactinemia.
    Hattori N
    J Pharmacol Sci; 2003 Jul; 92(3):171-7. PubMed ID: 12890882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.